Page last updated: 2024-10-27

gliclazide and Alcohol Drinking

gliclazide has been researched along with Alcohol Drinking in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.

Research Excerpts

ExcerptRelevanceReference
"In patients with type 2 diabetes, moderate alcohol use, particularly wine consumption, is associated with reduced risks of cardiovascular events and all-cause mortality."2.79The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. ( Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blomster, JI1
Zoungas, S1
Chalmers, J1
Li, Q1
Chow, CK1
Woodward, M1
Mancia, G1
Poulter, N1
Williams, B1
Harrap, S1
Neal, B1
Patel, A1
Hillis, GS1

Trials

1 trial available for gliclazide and Alcohol Drinking

ArticleYear
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
    Diabetes care, 2014, Volume: 37, Issue:5

    Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabet

2014